Circulating levels of Proglucagon-derived peptides are differentially regulated by the GLP-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: a 6-month long interventional study

Saved in:
Bibliographic Details
Published in:Diabetes, obesity & metabolism obesity & metabolism, 2023-05, Vol.25 (9), p.2561-2574
Main Authors: Stefanakis, Konstantinos, Kokkinos, Alexander, Argyrakopoulou, Georgia, Konstantinidou, Sofia K, Simati, Stamatia, Kouvari, Matina, Kumar, Ajay, Kalra, Bhanu, Kumar, Melina, Bontozoglou, Nikolaos, Kyriakopoulou, Konstantina, Mantzoros, Christos S
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1462-8902
1463-1326
DOI:10.1111/dom.15141